Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have ascertained how come aged people may be so defenseless to cancer and infections in the skin. The team from UCL has demonstrated in human volunteers that defective immunity in the skin is caused by an inability to mobilize essential defenses that would otherwise acknowledge menaces and absolved them prior to irreparable damage is done. Read more about Autoimmune Overview – Market Continues To Prosper

This breakthrough could be crucial for forestalling, managing or addressing many age-related skin health troubles. “Older people are very prone to having infections broadly and our studies in the skin of such subjects identifies one reason for this.” said Professor Arne Akbar from UCL, who led the study.

It’s actually unbelievably hard to get to the root of exactly which mechanisms cause the diseases that show up as a factor of old age. We wanted to uncover the workings of skin health in order to see why older people don’t deal well with skin infections and are prone to skin cancers also.

It has been known for some time that older people have compromised immunity and therefore defend themselves less well against infection and disease than younger people. In the past, the decrease in skin health was set down to potential defects in the leukocytes called T-cells that would usually help to identify and clear infection. Nevertheless, when experimentations were carried through with healthy young individuals under the age of 40 years and older humans over the age of 70 years in this study, it was shown that in fact there is nothing amiss with the T-cells in the older group; instead it is the unfitness of their skin tissue to attract T-cells where and when they are needed that is the source of reduced immunity.

Professor Akbar added: “Knowing this now raises the question of whether the equivalent defect also occurs in other tissues during maturing. Is it possible that, for example, lung tissues also fail to give out the right content to T-cells to bring them into the tissue to do their job? This may explain, in part, the higher rates of lung cancer, chest infections and pneumonia in older people, perhaps.

“We also, obviously, would like to know if it is conceivable to annul the skin defect in older people. We’ve done some experiments that show that, at least in the test tube, it is possible to make older skin express the escaping signs that attract T cells. This indicates that, in principle, the defect is entirely reversible. Once we get to the bottom of exactly which part of the signal to T-cells has gone wrong we might then be in a position to interfere to boost skin immunity in older people.”